Dual, Postsynaptic 5-HT2B Antagonist and 5-HT1A Agonist Approach to the Treatment of METH/MDMA Addiction and Related Problems. Part 1. The Hypothesis.
Author(s) -
P. Rajagopalan,
Achintya Bandopadhyaya,
Desikan R. Rajagopalan,
Raghavan Rajagopalan
Publication year - 2014
Publication title -
receptors and clinical investigation
Language(s) - English
Resource type - Journals
ISSN - 2330-0566
DOI - 10.14800/rci.103
Subject(s) - meth , agonist , postsynaptic potential , antagonist , 8 oh dpat , mdma , pharmacology , addiction , medicine , neuroscience , serotonin , psychology , chemistry , receptor , 5 ht receptor , monomer , organic chemistry , acrylate , polymer
There is compelling evidence to the theory that the 5-HT2B receptor plays a direct and crucial role in the mechanisms of actions of methamphetamine (METH) and of 3,4-methylenedioxy- methamphetamine (MDMA) leading to addiction. The involvement of 5-HT1A receptors in all of the biochemical and behavioural consequences such as anxiety, depression, memory impairment, and cognitive dysfunction, resulting from long-term METH/MDMA abuse, has also been unequivocally established. On the basis of these facts, a dual receptor hypothesis based on postsynaptic 5-HT2B receptor antagonist and 5-HT1A receptor agonist activities in the central nervous system (CNS), is proposed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom